Construction of pRMES and pTMES plasmids to test their expression ability of Nanobodies via the efficient T7 promoter


Abstract in English

Nanobody technology is considered as a promising molecular biology technique performed by means of the genetic engineering of special type of antibodies, existing exclusively in Camelidea. It enables the obtaining of small proteins, referred to as Nanobodies, which are characterized by high stability and solubility, are able to link to their specific antigens. After production, the Nanobody genes are cloned within plasmids of protein expression in bacteria, allowing their stable and continuous production for research and applied purposes.

References used

Abbady, A. Q., Al-Daoude, A., Al-Mariri, A., Zarkawi, M., and Muyldermans, S. (2012). Chaperonin GroEL a Brucella immunodominant antigen identified using Nanobody and MALDI-TOF-MS technologies. Vet. Immunol. Immunopathol. 146, 254-263
Abbady, A. Q., Al-Mariri, A., Zarkawi, M., Al-Assad, A., and Muyldermans, S. (2011). Evaluation of a nanobody phage display library constructed from a Brucellaimmunised camel. Vet. Immunol. Immunopathol. 142, 49-56
Abo Assali, L., Al-Mariri, A., Hamad, E., and Abbady, A.Q. (2012). Immunodetection of the recombinant GroEL by the Nanobody NbBruc02. World J. Microbiol. Biotechnol. 28, 2987-2995

Download